Block of the rapid component of the delayed rectifier potassium current by the prokinetic agent cisapride underlies drug-related lengthening of the QT interval

Circulation

Volumn 97, Issue 2, 1998, Pages 204-210

  Drolet, Benoit ^a   Khalifa, Majed ^a   Daleau, Pascal ^b   Hamelin, Bettina A ^a   Turgeon, Jacques ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Cisapride; Electrophysiology; Torsade de pointes

Indexed keywords

CISAPRIDE; PROKINETIC AGENT;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GUINEA PIG; HEART CELL CULTURE; HEART REPOLARIZATION; HUMAN; ISOLATED HEART; LONG QT SYNDROME; POTASSIUM CURRENT; PRIORITY JOURNAL; QT INTERVAL; TORSADE DES POINTES;

EID: 0031893970     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.2.204     Document Type: Article

References (46)

1. Chen HT, Goh MH, Pan S. The effect and mechanism of the prokinetic action ot cisapride on gastrointestinal smooth muscle. Gastroenterol Jpn. 1943;28:218-223.
2. McCallum RW, Prakash C, Campoli-Richards D, Goa KL. Cisapride: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders. Drugs. 1988;36:652-661.
3. McCallum RW. Cisapride: a new class of prokinetic agent. Am J Gastroenterol. 1991;86:135-149.
4. Bran S, Murray WA, Hirsch IB, Palmer JP. Long QT syndrome during high-dose cisapride. Arch Intern Med. 1995;155:765-768.
5. Lewin MB, Bryant RM, Fenrich AL, Grifka RG. Cisapride-induced long QT interval. J Pediatr. 1996;128:279-281.
6. Wysowski DK, Bacsanyi J. Cisapride and fatal arrhythmia. N Engl J Med. 1996;335:290-291.
7. Pettignano R, Chambliss CR, Darsey E, Heard M, Clack R. Cisapride-induced dysrhythmia in a pediatric patient receiving extracorporeal life support. Crit Care Med. 1996;24:1268-1271.
8. Farrington E. Cardiac toxicity with cisapride. Pediatr Nursing. 1996;22:256. Letter.
9. Olsson S, Edwards IR. Tachycardia during cisapride treatment. Br Med J. 1992;305:748-749.
10. Roden DM. The long QT syndrome and torsades de pointes: basic and clinical aspects. In: El-Sherif N, Samet P, eds. Cardiac Pacing ana Electrophysiology. Philadelphia, Pa: WB Saunders; 1991:265-284.
11. Keating MT. The long QT syndrome: a review of recent molecular genetic and physiological discoveries. Medicine. 1996;75:1-5.
12. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell. 1995;80:795-803.
13. Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, Moss AJ, Towbin JA, Keating MT. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell. 1995;80:805-811.
14. Bennett PB, Yazawa K, Makita N, George AL Jr. Molecular mechanism for an inherited cardiac arrhythmia. Nature. 1995;376:683-685.
15. Wang Q, Curran ME, Splawski I, Bum TC, MillhollandJM, VanRaay TJ, Shen J, Timothy KW, Vincent GM, de Jager T, Schwartz PJ, Towbin JA, Moss AJ, Atkinson DL, Landes GM, Connors TD, Keating MT. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nqt Genet. 1996;12:17-23.
16. Cranefield PF, Aronson RS. Torsades de pointes and early afterdepolarizations. Cardiovasc Drugs Ther. 1991;5:531-538.
17. El-Sherif N. QTU prolongation and polymorphic ventricular tachyarrhythmias due to bradycardia-dependent early after depolarization. Circ Res. 1988;63:286-305.
18. Roden DM, Thompson KA, Hoffman BF. Clinical features and basic mechanisms of quinidine-induced arrhythmias. J Am Coll Cardiol. 1986;8:73-78.
19. Honig PK, Wortham DC, Zamani K, Conner DP, Mullin JC, Cantilena LR. Terfenadine-ketoconazole interaction: pharmacokinetic and electrocardiographic consequences. JAAM. 1993;269:1513-1518.
20. Martyn R, Somberg JC, Kerin NZ. Proarrhythmia of nonantiarrhythmic drugs. Am Heart J. 1993;126:201-205.
21. Matsuura H, Ehara T, Imoto Y. An analysis of the delayed outward current in single ventricular cells of the guinea-pig. Pflugers Arch. 1987;410:596-603.
22. Liu DW, Gintant GA, Antzelevitch C. Ionic bases for electrophysiological distinctions among epicardial, midmyocardial, and endocardial myocytes from the free wall of the canine left ventricle. Circ Res. 1993;72:671-687.
23. + current in human ventricular myocytes. Circ Res. 1996;78:689-696.
24. + current: differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol. 1990;96:195-215.
25. Ks play a role in the reverse rate dependences of class III agents? Circ Res. 1996;78:26-37.
26. Daleau P, Turgeon J. Angiotensin II modulates the delayed rectifier potassium current of guinea pig ventricular myocytes. Pflugers Arch. 1994;427:553-555.
27. Kr channel. J Gen Physiol. 1996;107:611-619.
28. Puisieux FL, Adamantidis MM, Dumotier BM, Dupuis BA. Cisaprideinduced prolongation ot cardiac action potential and early afterdepolarizations in rabbit Purkinje fibers. Br J Pharmacol. 1996;117:1377-1379.
29. + currents. Pflugers Arch. 1992;420:180-186.
30. Srivastava MS, Carter EM. An Introduction to Applied Multivariate Statistics. New York, NY: Elsevier Science Publishing Co Inc; 1983.
31. Wrighton SA, Ring BJ. Inhibition ot human CYP3A catalyzed 1'-hydroxy midazolam formation by ketoconazole, nifedipine, erythromycin, cimetidine, and nizatidine. Pharm Res. 1994;11:921-924.
32. Ervine CM, Matthew DE, Brennan B, Houston JB. Comparison of ketoconazole and fluconazole as cytochrome P450 inhibitors: use of steady-state infusion approach to achieve plasma concentration-response relationships. Drug Metab Dispos. 1996;24:211-215.
33. McComb JM, Campbell NPS, Cleland J. Recurrent ventricular tachycardia associated with QT prolongation after mitral valve replacement and its association with intravenous administration of erythromycin. Am J Cardiol. 1984;54:922-923.
34. Nattel S, Ranger S, Talajic M, Lemery R, Roy D. Erythromycin-induced long QT syndrome: concordance with quinidine and underlying cellular electrophysiologic mechanism. Am J Med. 1990;89:235-238.
35. Paserchia LA, Hewett J, Woosley RL. Effects of ketoconazole on QTc. Clin Pharmacol Ther. 1994;55:146. Abstract.
36. Daleau P, Lessard E, Groleau MF, Turgeon J, Erythromycin blocks the rapid component of the delayed rectifier potassium current and lengthens repolarization of guinea pig ventricular myocytes. Circulation. 1995;91:3010-3016.
37. Nemeth PR, Ort CA, Zafirov DH, Wood JD. Interactions between serotonin and cisapride on myenteric neurons. Eur J Pharmacol. 1985;108:77-83.
38. Cooke HJ, Carey HV. Pharmacological analysis of 5-hydroxytryptamine actions on guinea-pig ileal mucosa. Eur J Pharmacol. 1985;111:329-337.
39. 2 receptors. Gut. 1987;28:844-848.
40. Wang Z, Fermini B, Nattel S. Delayed rectifier outward current and repolarization in human atrial myocytes. Circ Res. 1993;73:276-285.
41. Wang Z, Fermini B, Nattel S. Rapid and slow components of delayed rectifier current in human atrial myocytes. Cardiovasc Res. 1994;28:1540-1546.
42. + current, by the diuretic agent indapamide in guinea pig ventricular myocytes. Circ Res. 1994;75:879-886.
43. K) in guinea pig ventricular myocytes. Circ Res. 1994;74:1114-1120.
44. 1-receptor antagonists astemizole and terfenadine compared with chlorpheniramine and pyrilamine. Circ Res. 1995;76:110-119.
45. Khalifa M, Daleau P, Turgeon J. The histamine H1-receptor antagonist diphenhydramine blocks the delayed rectifier potassium current. Pacing Clin Electrophysiol. 1995;18:936. Abstract.
46. Khalifa M, Drolet B, Hamelin BA, O'Hara G, Philippon F, Gilbert M, Turgeon J. Modulation of cardiac repolarization by venlafaxine. Can J Cardiol. 1996;12:85E. Abstract.